GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medartis Holding AG (XSWX:MED) » Definitions » EV-to-EBITDA

Medartis Holding AG (XSWX:MED) EV-to-EBITDA : 32.04 (As of May. 31, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Medartis Holding AG EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medartis Holding AG's enterprise value is CHF967.1 Mil. Medartis Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was CHF30.2 Mil. Therefore, Medartis Holding AG's EV-to-EBITDA for today is 32.04.

The historical rank and industry rank for Medartis Holding AG's EV-to-EBITDA or its related term are showing as below:

XSWX:MED' s EV-to-EBITDA Range Over the Past 10 Years
Min: 19.61   Med: 41.17   Max: 110.37
Current: 32.03

During the past 11 years, the highest EV-to-EBITDA of Medartis Holding AG was 110.37. The lowest was 19.61. And the median was 41.17.

XSWX:MED's EV-to-EBITDA is ranked worse than
78.54% of 494 companies
in the Medical Devices & Instruments industry
Industry Median: 15.78 vs XSWX:MED: 32.03

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-31), Medartis Holding AG's stock price is CHF79.50. Medartis Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was CHF0.280. Therefore, Medartis Holding AG's PE Ratio (TTM) for today is 283.93.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Medartis Holding AG EV-to-EBITDA Historical Data

The historical data trend for Medartis Holding AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medartis Holding AG EV-to-EBITDA Chart

Medartis Holding AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.72 58.18 83.68 40.97 22.64

Medartis Holding AG Semi-Annual Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.68 - 40.97 - 22.64

Competitive Comparison of Medartis Holding AG's EV-to-EBITDA

For the Medical Devices subindustry, Medartis Holding AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medartis Holding AG's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medartis Holding AG's EV-to-EBITDA falls into.


;
;

Medartis Holding AG EV-to-EBITDA Calculation

Medartis Holding AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=967.077/30.184
=32.04

Medartis Holding AG's current Enterprise Value is CHF967.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was CHF30.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medartis Holding AG  (XSWX:MED) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Medartis Holding AG's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=79.50/0.280
=283.93

Medartis Holding AG's share price for today is CHF79.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was CHF0.280.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Medartis Holding AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medartis Holding AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Medartis Holding AG Business Description

Traded in Other Exchanges
Address
Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from EMEA and also has a presence in APAC, LATAM, and USA.